(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 531.85%8.16M | -76.35%-8.8M | -163.24%-13.25M | -254.33%-1.76M | -167.77%-4.61M | 5.59%-1.89M | -103.30%-4.99M | 34.06%-5.04M | 170.21%1.14M | 10.36%-1.72M |
Net income from continuing operations | 196.00%2.95M | 18.20%-6.21M | 3.50%-10.43M | 128.47%1.71M | 38.52%-1.47M | -191.56%-3.07M | -453.94%-7.59M | -266.62%-10.81M | -3,422.35%-5.99M | -40.94%-2.4M |
Operating gains losses | -336.74%-5.43M | -43.65%1.9M | -44.81%-2.09M | -745.54%-4.74M | -74.54%522K | -1.97%-1.24M | 295.98%3.36M | 60.44%-1.45M | -232.70%-560K | 1,431.17%2.05M |
Depreciation and amortization | 233.78%494K | -12.15%94K | 1.82%559K | 29.73%144K | 48.15%160K | 28.70%148K | -50.23%107K | -36.09%549K | -45.59%111K | -49.77%108K |
Asset impairment expenditure | ---- | ---- | --325K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Remuneration paid in stock | -2.29%384K | 12.66%534K | -43.81%3.09M | -45.22%1.9M | -31.78%322K | -19.30%393K | -55.70%474K | 218.63%5.49M | 1,034.75%3.46M | 0.00%472K |
Deferred tax | --0 | --245K | 2,146.43%1.15M | ---- | ---- | --0 | --0 | 75.22%-56K | ---- | ---- |
Other non cashItems | -111.63%-379K | -84.36%232K | -757.93%-2.65M | -304.35%-2.68M | -172.43%-4.71M | 7,304.55%3.26M | 2,146.97%1.48M | 85.74%-309K | 169.88%1.31M | -905.81%-1.73M |
Change In working capital | 839.50%10.15M | -97.74%-5.59M | -306.73%-3.19M | -84.85%434K | 352.65%571K | -266.84%-1.37M | -293.18%-2.83M | 202.52%1.55M | 1,097.91%2.86M | 61.17%-226K |
-Change in receivables | 7.01%458K | 52.00%-552K | -334.47%-1.31M | -79.01%161K | -1,305.66%-745K | 282.91%428K | -1,593.51%-1.15M | 153.97%557K | 271.21%767K | 90.26%-53K |
-Change in inventory | ---4.47M | ---4.51M | ---763K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
-Change in prepaid assets | 102.03%48K | 57.00%-574K | -3,215.56%-1.4M | -65.26%577K | 1,047.51%1.72M | -452.46%-2.36M | -32.44%-1.34M | 155.56%45K | 548.83%1.66M | -796.15%-181K |
-Change in payables and accrued expense | 2,424.15%14.11M | 112.28%42K | -70.63%277K | 5.28%459K | -5,087.50%-399K | 94.77%559K | -261.32%-342K | 339.34%943K | 558.95%436K | 112.50%8K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 531.85%8.16M | -76.35%-8.8M | -163.24%-13.25M | -254.33%-1.76M | -167.77%-4.61M | 5.59%-1.89M | -103.30%-4.99M | 34.06%-5.04M | 170.21%1.14M | 10.36%-1.72M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -44.04%-45M | -61.20%-22.48M | -22.13%-129.4M | -183.30%-50.64M | 0.82%-33.57M | -16.26%-31.24M | 49.01%-13.95M | -92.33%-105.95M | 38.35%-17.87M | -95.52%-33.85M |
Net PPE purchase and sale | -43.08%-44.7M | -351.99%-63.04M | -21.20%-128.35M | -177.71%-49.64M | 0.83%-33.52M | -16.26%-31.24M | 49.01%-13.95M | -84.42%-105.9M | 38.35%-17.87M | -95.80%-33.8M |
Net other investing changes | ---40.85M | --40.55M | -2,000.00%-1.05M | ---1M | ---- | ---- | ---- | -102.65%-50K | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -44.04%-45M | -61.20%-22.48M | -22.13%-129.4M | -183.30%-50.64M | 0.82%-33.57M | -16.26%-31.24M | 49.01%-13.95M | -92.33%-105.95M | 38.35%-17.87M | -95.52%-33.85M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -17.84%2.55M | -68.04%51.36M | 173.27%162.13M | -419.65%-1.48M | -43.84%-210K | 1,077.60%3.1M | 167.52%160.72M | -25.63%59.33M | 0.00%-285K | -78.05%-146K |
Net issuance payments of debt | 3,841.29%25.55M | -957.55%-1.12M | -270.84%-2.25M | -980.17%-1.25M | -52.55%-209K | -478.81%-683K | 55.08%-106K | -86.20%-607K | 23.68%-116K | -136.21%-137K |
Net common stock issuance | 23.43%5M | -42.37%28.75M | -16.04%53.94M | --0 | --0 | --4.05M | -22.35%49.89M | -24.61%64.24M | --0 | --0 |
Cash dividends paid | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --149K | 76.00%44K | --25K | --0 | --0 | --0 | --25K | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | ---1.09M | ---482K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net other financing activities | -9,998.13%-27.06M | -78.21%24.17M | 2,664.26%110.42M | -34.91%-228K | 88.89%-1K | -9.84%-268K | 2,955.66%110.91M | 16.63%-4.31M | 10.11%-169K | 62.50%-9K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -17.84%2.55M | -68.04%51.36M | 173.27%162.13M | -419.65%-1.48M | -43.84%-210K | 1,077.60%3.1M | 167.52%160.72M | -25.63%59.33M | 0.00%-285K | -78.05%-146K |
Net cash flow | ||||||||||
Beginning cash position | -68.49%47.03M | 260.90%26.97M | -87.36%7.47M | 229.99%80.81M | 98.18%119.32M | 66.95%149.26M | -87.36%7.47M | 40.52%59.13M | -72.80%24.49M | -44.89%60.21M |
Current changes in cash | -14.18%-34.29M | -85.83%20.08M | 137.70%19.47M | -216.65%-53.88M | -7.49%-38.4M | -2.88%-30.03M | 368.33%141.78M | -402.98%-51.66M | 44.94%-17.02M | -84.92%-35.72M |
Effect of exchange rate changes | -126.04%-25K | -850.00%-30K | --27K | --42K | ---115K | --96K | --4K | --0 | --0 | --0 |
End cash Position | -89.35%12.71M | -68.49%47.03M | 260.90%26.97M | 260.90%26.97M | 229.99%80.81M | 98.18%119.32M | 66.95%149.26M | -87.36%7.47M | -87.36%7.47M | -72.80%24.49M |
Free cash from | -10.28%-36.54M | -279.37%-71.83M | -27.65%-141.6M | -207.22%-51.4M | -7.35%-38.14M | -14.74%-33.13M | 36.46%-18.94M | -70.52%-110.93M | 45.36%-16.73M | -85.17%-35.53M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.